MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 2181 to 2200 of 166,322 approvalsPage 110 of 8317

Roxadustat Capsules

Approval Number: 国药准字H20249732
Registration: Dec 17, 2024
南京正大天晴制药有限公司

Roxadustat Capsules

Approval Number: 国药准字H20249733
Registration: Dec 17, 2024
湖南明瑞制药股份有限公司

Roxadustat Capsules

Approval Number: 国药准字H20249729
Registration: Dec 17, 2024
江西山香药业有限公司

Tedizolid Phosphate for Injection

Approval Number: 国药准字H20249760
Registration: Dec 17, 2024
四川美大康佳乐药业有限公司

Azithromycin for Suspension

Approval Number: 国药准字H20249741
Registration: Dec 17, 2024
海南斯达制药有限公司

Iomeprol Injection

Approval Number: 国药准字H20249738
Registration: Dec 17, 2024
成都倍特药业股份有限公司

Tadalafil Tablets

Approval Number: 国药准字H20249762
Registration: Dec 17, 2024
湖南威特制药股份有限公司

Metformin Hydrochloride and Empagliflozin Tablets（Ⅵ）

Approval Number: 国药准字H20249745
Registration: Dec 17, 2024
杭州朱养心药业有限公司

Skin Prick Solution for Blattella germanica Allergens

Approval Number: 国药准字S20240055
Registration: Dec 17, 2024
浙江我武生物科技股份有限公司

Eltrombopag Olamine For Suspension

Approval Number: 国药准字H20249763
Registration: Dec 17, 2024
山东则正医药技术有限公司

Lactulose Oral Solution

Approval Number: 国药准字H20249749
Registration: Dec 17, 2024
青岛黄海制药有限责任公司

Mosunetuzumab Injection

Approval Number: 国药准字SJ20240048
Registration: Dec 17, 2024
Roche Pharma (Schweiz) AG

Mosunetuzumab Injection

Approval Number: 国药准字SJ20240049
Registration: Dec 17, 2024
Roche Pharma (Schweiz) AG

Compound Ipratropium Bromide Solution for Inhalation

Approval Number: 国药准字H20249758
Registration: Dec 17, 2024
南京力成药业有限公司

Roxadustat Capsules

Approval Number: 国药准字H20249730
Registration: Dec 17, 2024
江西山香药业有限公司

Metformin Hydrochloride and Empagliflozin Tablets（Ⅵ）

Approval Number: 国药准字H20249744
Registration: Dec 17, 2024
浙江诺得药业有限公司

Olopatadine Hydrochloride Eye Drops

Approval Number: 国药准字H20249755
Registration: Dec 17, 2024
石家庄格瑞药业有限公司

Sildenafil Citrate Orodispersible Tablets

Approval Number: 国药准字H20249739
Registration: Dec 17, 2024
金鸿药业股份有限公司拱北分公司

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.